Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, today reported financial results for its third quarter ended October 2, 2021.

Third Quarter 2021 Financial Highlights1

  • Net revenues were $106.4 million, an increase of 12.7% year-over-year.
  • Gross profit was $23.0 million, or gross margin of 21.6% of net revenues.
  • Net loss was $54.8 million, or $0.87 per common share. Net loss as a percentage of net revenues was -51.5%.
  • Adjusted EBITDA was a loss of $36.8 million, or -34.5% of net revenues.

Beyond Meat President and CEO Ethan Brown commented, "Our third quarter results reflect variability as we saw a decline from record net revenues just a quarter ago. Despite current disruptions, we remain focused on rapidly advancing key building blocks of long-term growth. Whether scaling products and infrastructure for our strategic quick serve restaurant partners, bringing new product to retail markets, or investing in innovation, commercialization, and production capabilities here in the U.S., EU, and China, we believe we are steadily executing against our vision of being tomorrow’s global protein company."

Brown added, "Near-term market and operating conditions notwithstanding, we remain committed to our long-term strategy. As we continue to advance the field of plant-based meat through innovation and bold investment in domestic and global operations, the consumer is only being made more aware of the relevance and urgency of our mission. And although we see continued uncertainty for the balance of this year, we look to 2022 with enthusiasm as we expect to bring to life, together with our strategic partners, product and production capacity that we’ve been steadfastly investing in throughout the pandemic."

_________________________1 This release includes references to non-GAAP financial measures. Refer to “Non-GAAP Financial Measures” later in this release for the definitions of the non-GAAP financial measures presented and a reconciliation of these measures to their closest comparable GAAP measures.

Third Quarter 2021

Net revenues increased 12.7% to $106.4 million in the third quarter of 2021, compared to $94.4 million in the year-ago period. Growth in net revenues was primarily due to increased sales to international customers, which increased 142.5% compared to the year-ago period, mainly reflecting expansion of overall distribution, accelerated orders and, to a lesser extent, new product introductions. The increase in international net revenues was partially offset by decreased U.S. net revenues, which declined 13.9% compared to the year-ago period, primarily as a result of lower overall demand, and operational challenges with severe weather as a key driver, partially offset by sales from new product introductions. In aggregate, net revenue per pound of $5.34 during the third quarter of 2021 was roughly equivalent to the year-ago period.

Net revenues by channel (unaudited):

    Three Months Ended   Change
(in thousands)   October 2,2021   September 26,2020   Amount   %
U.S.:                
Retail   $ 52,361     $ 62,057     $ (9,696 )   (15.6 )%
Foodservice   15,139     16,325     (1,186 )   (7.3 )%
U.S. net revenues   67,500     78,382     (10,882 )   (13.9 )%
International:                
Retail   21,391     7,975     13,416     168.2 %
Foodservice   17,541     8,079     9,462     117.1 %
International net revenues   38,932     16,054     22,878     142.5 %
Net revenues   $ 106,432     $ 94,436     $ 11,996     12.7 %
    Nine Months Ended   Change
(in thousands)   October 2,2021   September 26,2020   Amount   %
U.S.:                
Retail   $ 193,382     $ 202,019     $ (8,637 )   (4.3 )%
Foodservice   55,842     45,442     10,400     22.9 %
U.S. net revenues   249,224     247,461     1,763     0.7 %
International:                
Retail   67,134     23,499     43,635     185.7 %
Foodservice   47,664     33,888     13,776     40.7 %
International net revenues   114,798     57,387     57,411     100.0 %
Net revenues   $ 364,022     $ 304,848     $ 59,174     19.4 %
                               

Gross profit was $23.0 million, or gross margin of 21.6% of net revenues, in the third quarter of 2021, compared to $25.5 million, or gross margin of 27.0% of net revenues, in the year-ago period. During the third quarter of 2020, gross profit included $1.8 million of expenses related to inventory write-offs and reserves and product repacking costs attributable to COVID-19. Excluding these costs, of which there were none in the third quarter of 2021, Adjusted gross profit in the year-ago period was $27.3 million, or Adjusted gross margin of 28.9% of net revenues. Compared to Adjusted gross margin in the year-ago period, the decrease in gross margin in the third quarter of 2021 was primarily due to increased transportation costs, increased inventory write-offs, higher warehousing costs, and increased depreciation and amortization expense, partially offset by reduced co-manufacturer fees.

Loss from operations in the third quarter of 2021 was $54.0 million compared to $18.5 million in the year-ago period. The increase in loss from operations was primarily driven by growth in overall headcount levels mainly to support the Company's operations, innovation and marketing capabilities, increased investments in marketing activities, higher professional services fees related to recently established consulting agreements, higher restructuring expenses primarily reflecting increased legal costs, increased production trial activities, and higher outbound freight costs included in the Company's selling expenses.

Net loss was $54.8 million in the third quarter of 2021 compared to $19.3 million in the year-ago period. Net loss per common share was $0.87 in the third quarter of 2021 compared to $0.31 in the year-ago period. During the third quarter of 2020, net loss included $1.8 million in expenses attributable to COVID-19, specifically related to inventory write-offs and reserves and product repacking costs. Excluding these costs, Adjusted net loss was $17.5 million, or $0.28 per common share, in the third quarter of 2020. There were no similar costs in the third quarter of 2021.

Adjusted EBITDA was a loss of $36.8 million, or -34.5% of net revenues, in the third quarter of 2021 compared to an Adjusted EBITDA loss of $4.3 million, or -4.5% of net revenues, in the year-ago period.

Balance Sheet and Cash Flow Highlights

The Company’s cash and cash equivalents balance was $886.4 million and total outstanding debt was $1.1 billion as of October 2, 2021. Net cash used in operating activities was $191.0 million for the nine months ended October 2, 2021, compared to $42.7 million for the year-ago period. Capital expenditures totaled $104.3 million for the nine months ended October 2, 2021, compared to $38.0 million for the year-ago period. The increase in capital expenditures was primarily due to the Company’s continued investments in production equipment and facilities related to capacity expansion initiatives domestically and abroad.

Fourth Quarter 2021 Outlook

The Company's operating environment continues to be affected by near-term uncertainty related to COVID-19 and its potential impact including on demand levels, labor availability and supply chain disruptions. Management's outlook assumes reasonable containment of COVID-19 infection rates both in the U.S. and abroad, but the Company acknowledges that its operating results could differ meaningfully from the expectations set forth below if its assumptions related to COVID-19 and the effects from COVID-19 do not materialize. Based on management's best assessment of the environment today, the Company is providing the following guidance for the fourth quarter of 2021:

  • Net revenues in the range of $85 million to $110 million.

Embedded in the fourth quarter guidance range above are management's expectations of a moderation in sales growth across all channels as a result of, among other things, the Company's fourth quarter 2021 period containing 5 fewer shipping days compared to the fourth quarter of 2020, impacts associated with knock-on effects from operational challenges in the third quarter of 2021, ongoing operator challenges related to labor issues as well as general caution among customers based on COVID-19-related uncertainty, and accelerated orders in the third quarter of 2021 that would otherwise have been expected to materialize in the fourth quarter.

Conference Call and Webcast

The Company will host a conference call and webcast to discuss these results with additional comments and details today at 5:00 p.m. Eastern, 2:00 p.m. Pacific. Investors interested in participating in the live call can dial 201-389-0879. The conference call webcast will be available live over the Internet through the “Investors” section of the Company’s website at www.beyondmeat.com and later archived.

About Beyond Meat

Beyond Meat, Inc. (NASDAQ: BYND) is one of the fastest growing publicly-traded food companies in the United States, offering a portfolio of revolutionary plant-based proteins made from simple ingredients without GMOs, bioengineered ingredients, hormones, antibiotics or cholesterol. Founded in 2009, Beyond Meat products are designed to have the same taste and texture as animal-based meat while being better for people and the planet. Beyond Meat’s brand commitment, Eat What You Love™, represents a strong belief that there is a better way to feed our future and that the positive choices we all make, no matter how small, can have a great impact on our personal health and the health of our planet. By shifting from animal-based meat to plant-based protein, we can positively impact four growing global issues: human health, climate change, constraints on natural resources and animal welfare. As of September 2021, Beyond Meat had products available at approximately 128,000 retail and foodservice outlets in over 85 countries worldwide. Visit www.BeyondMeat.com and follow @BeyondMeat, #BeyondBurger and #GoBeyond on Facebook, Instagram, Twitter and TikTok.

Forward-Looking Statements

Certain statements in this release constitute “forward-looking statements" within the meaning of the federal securities laws. These statements are based on management's current opinions, expectations, beliefs, plans, objectives, assumptions and projections regarding financial performance, prospects, future events and future results, including ongoing uncertainty related to the COVID-19 pandemic, including the ultimate duration, magnitude and effects of the pandemic and, in particular, the impact to the foodservice channel, operations and supply chains, growth trends, our international expansion plans, market share, new and existing customers and expense trends, among other matters, and involve known and unknown risks that are difficult to predict. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “outlook,” “potential,” “continue,” “likely,” “will,” “would” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. These forward-looking statements are only predictions, not historical fact, and involve certain risks and uncertainties, as well as assumptions. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by which or whether, such performance or results will be achieved. Actual results, levels of activity, performance, achievements and events could differ materially from those stated, anticipated or implied by such forward-looking statements. While Beyond Meat believes that its assumptions are reasonable, it is very difficult to predict the impact of known factors and, in particular, the COVID-19 pandemic, and, of course, it is impossible to anticipate all factors that could affect actual results. There are many risks and uncertainties that could cause actual results to differ materially from forward-looking statements made herein including, but not limited to, the effects of global outbreaks of pandemics or contagious diseases or fear of such outbreaks (such as COVID-19), including on our ability to expand in new geographic markets or the timing of such expansion efforts; a resurgence of COVID-19 and the discovery and spread of COVID-19 variants, such as the Delta variant, which could slow, halt or reverse the reopening process, or result in the reinstatement of social distancing measures, business closures, restrictions on operations, quarantines and travel bans; the impact of labor and supply chain disruptions; the impact of uncertainty as a result of doing business in China; government or employer mandates requiring certain behaviors from employees due to COVID-19, including COVID-19 vaccine mandates, which could result in employee attrition at the Company, suppliers and customers as well as difficulty securing future labor needs; the impact of adverse and uncertain economic and political conditions in the U.S. and international markets; the volatility of capital markets and other macroeconomic factors; our ability to effectively manage our growth; our ability to identify and execute cost-down initiatives intended to achieve price parity with animal protein; the success of operations conducted by joint ventures; the effects of increased competition from our market competitors and new market entrants; changes in the retail landscape, including the timing and level of trade and promotion discounts, our ability to grow market share and increase household penetration, repeat buying rates and purchase frequency, and our ability to maintain and increase sales velocity of our products; the timing and success of distribution expansion and new product introductions in increasing revenues and market share; the timing and success of strategic partnership launches and limited time offerings resulting in permanent menu items; our estimates of the size of market opportunities; our ability to effectively expand our manufacturing and production capacity; our ability to accurately forecast demand for our products and manage our inventory, including the impact of customer orders ahead of holidays and shelf reset activities, and supply chain and labor disruptions; our operational effectiveness and ability to fulfill orders in full and on time; variations in product selling prices and costs, and the mix of products sold; our ability to successfully enter new geographic markets, manage our international expansion and comply with any applicable laws and regulations, including risks associated with doing business in foreign countries, substantial investments in our manufacturing operations in China and The Netherlands, and our ability to comply with the U.S. Foreign Corrupt Practices Act or other anti-corruption laws; the success of our marketing initiatives and the ability to grow brand awareness, maintain, protect and enhance our brand, attract and retain new customers and grow our market share; our ability to attract, maintain and effectively expand our relationships with key strategic foodservice partners; our ability to attract and retain our suppliers, distributors, co-manufacturers and customers; our ability to procure sufficient high-quality raw materials to manufacture our products; the availability of pea and other protein that meets our standards; our ability to diversify the protein sources used for our products; our ability to differentiate and continuously create innovative products, respond to competitive innovation and achieve speed-to-market; our ability to successfully execute our strategic initiatives; the volatility associated with ingredient, packaging and other input costs; the impact of inflation across the economy, including higher food, grocery, transportation and fuel costs; real or perceived quality or health issues with our products or other issues that adversely affect our brand and reputation; our ability to accurately predict consumer taste preferences, trends and demand and successfully innovate, introduce and commercialize new products and improve existing products, including in new geographic markets; significant disruption in, or breach in security of our information technology systems and resultant interruptions in service and any related impact on our reputation; management and key personnel changes, the attraction and retention of qualified employees and key personnel, and our ability to maintain our company culture as we grow; the effects of natural or man-made catastrophic or severe weather events particularly involving our or any of our co-manufacturers’ manufacturing facilities or our suppliers’ facilities; the impact of marketing campaigns aimed at generating negative publicity regarding our products, brand and the plant-based industry category; the effectiveness of our internal controls; our significant indebtedness and ability to pay such indebtedness; risks related to our debt, including limitations on our cash flow from operations and our ability to satisfy our obligations under the convertible senior notes; our ability to raise the funds necessary to repurchase the convertible senior notes for cash, under certain circumstances, or to pay any cash amounts due upon conversion; provisions in the indenture governing the convertible senior notes delaying or preventing an otherwise beneficial takeover of us; any adverse impact on our reported financial condition and results from the accounting methods for the convertible senior notes; estimates of our expenses, future revenues, capital expenditures, capital requirements and our needs for additional financing; our ability to meet our obligations under our campus headquarters lease, the timing of occupancy and completion of the build-out of our space, cost overruns and the impact of COVID-19 on our space demands; changes in laws and government regulation affecting our business, including Food and Drug Administration and Federal Trade Commission governmental regulation, and state, local and foreign regulation; new or pending legislation, or changes in laws, regulations or policies of governmental agencies or regulators, both in the U.S. and abroad, affecting plant-based meat, the labeling or naming of our products, or our brand name or logo; the failure of acquisitions and other investments to be efficiently integrated and produce the results we anticipate; the financial condition of, and our relationships with our suppliers, co-manufacturers, distributors, retailers and foodservice customers, and their future decisions regarding their relationships with us; the ability of our suppliers and co-manufacturers to comply with food safety, environmental or other laws and regulations; seasonality, including increased levels of purchasing by customers ahead of holidays, customer shelf reset activity and the timing of product restocking by our retail customers; the sufficiency of our cash and cash equivalents to meet our liquidity needs and service our indebtedness; economic conditions and the impact on consumer spending; outcomes of legal or administrative proceedings, or new legal or administrative proceedings filed against us; our, our suppliers’ and our co-manufacturers’ ability to protect our proprietary technology and intellectual property adequately; the impact of tariffs and trade wars; the impact of changes in tax laws; foreign exchange rate fluctuations; and the risks discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 and the Company’s Quarterly Report on Form 10-Q for the quarter ended July 3, 2021 filed with the SEC on August 12, 2021, and the Company’s Quarterly Report on Form 10-Q for the quarter ended October 2, 2021 to be filed with the SEC, as well as other factors described from time to time in the Company's filings with the SEC. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above. Such forward-looking statements are made only as of the date of this release. Beyond Meat undertakes no obligation to publicly update or revise any forward-looking statement because of new information, future events, changes in assumptions or otherwise, except as otherwise required by law. If we do update one or more forward-looking statements, no inference should be made that we will make additional updates with respect to those or other forward-looking statements.

Non-GAAP Financial MeasuresThe Company refers to certain financial measures that are not recognized under U.S. generally accepted accounting principles (GAAP) in this press release, including: Adjusted gross profit, Adjusted gross margin, Adjusted net loss, Adjusted net loss per diluted common share, Adjusted EBITDA and Adjusted EBITDA as a % of net revenues. See “Non-GAAP Financial Measures” below for additional information and reconciliations of such non-GAAP financial measures.

Availability of Information on Beyond Meat’s Website and Social Media ChannelsInvestors and others should note that Beyond Meat routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Beyond Meat Investor Relations website. We also intend to use certain social media channels as a means of disclosing information about us and our products to consumers, our customers, investors and the public (e.g., @BeyondMeat, #BeyondBurger and #GoBeyond on Facebook, Instagram and Twitter, and @BeyondMeatOfficial on TikTok). The information posted on social media channels is not incorporated by reference in this press release or in any other report or document we file with the SEC. While not all of the information that the Company posts to the Beyond Meat Investor Relations website or to social media accounts is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media, and others interested in Beyond Meat to review the information that it shares at the “Investors” link located at the bottom of the Company’s webpage at https://investors.beyondmeat.com/investor-relations and to sign up for and regularly follow the Company’s social media accounts. Users may automatically receive email alerts and other information about the Company when enrolling an email address by visiting "Request Email Alerts" in the "Investors" section of Beyond Meat’s website at https://investors.beyondmeat.com/investor-relations.

Contacts

Media:Shira Zackai917-715-8522szackai@beyondmeat.com

Investors: Fitzhugh Taylor and Raphael Grossbeyondmeat@icrinc.com

 
BEYOND MEAT, INC. AND SUBSIDIARIESCondensed Consolidated Statements of Operations(In thousands, except share and per share data)(unaudited)
         
    Three Months Ended   Nine Months Ended
    October 2,2021   September 26,2020   October 2,2021   September 26,2020
Net revenues   $ 106,432     $ 94,436     $ 364,022     $ 304,848  
Cost of goods sold   83,456     68,908     260,986     207,978  
Gross profit   22,976     25,528     103,036     96,870  
Research and development expenses   14,862     8,278     44,610     20,488  
Selling, general and administrative expenses   56,362     33,560     143,602     95,167  
Restructuring expenses   5,750     2,146     12,068     6,028  
Total operating expenses   76,974     43,984     200,280     121,683  
Loss from operations   (53,998 )   (18,456 )   (97,244 )   (24,813 )
Other (expense) income, net                
Interest expense   (1,005 )   (689 )   (2,656 )   (1,963 )
Other, net   759     (85 )   (631 )   (829 )
Total other expense, net   (246 )   (774 )   (3,287 )   (2,792 )
Loss before taxes   (54,244 )   (19,230 )   (100,531 )   (27,605 )
Income tax (benefit) expense   (23 )   55     27     70  
Equity in losses of unconsolidated joint venture   595         1,176      
Net loss   $ (54,816 )   $ (19,285 )   $ (101,734 )   $ (27,675 )
Net loss per share available to common stockholders—basic and diluted   $ (0.87 )   $ (0.31 )   $ (1.61 )   $ (0.45 )
Weighted average common shares outstanding—basic and diluted   63,280,122     62,487,152     63,111,703     62,114,399  
                         
 
BEYOND MEAT, INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(In thousands, except share and per share data)
(unaudited)
  October 2,2021   December 31,2020
Assets      
Current assets:      
Cash and cash equivalents $ 886,442     $ 159,127  
Accounts receivable 48,849     35,975  
Inventory 193,490     121,717  
Prepaid expenses and other current assets 24,341     15,407  
Total current assets $ 1,153,122     $ 332,226  
Property, plant, and equipment, net 197,290     115,299  
Operating lease right-of-use assets 25,444     14,570  
Prepaid lease costs, non-current 49,456      
Other non-current assets, net 7,062     5,911  
Total assets $ 1,432,374     $ 468,006  
Liabilities and Stockholders’ Equity:      
Current liabilities:      
Accounts payable $ 45,387     $ 53,071  
Wages payable 4,269     2,843  
Accrued bonus 1,400     57  
Current portion of operating lease liabilities 3,962     3,095  
Short-term borrowings under revolving credit facility     25,000  
Accrued expenses and other current liabilities 19,091     4,830  
Short-term finance lease liabilities 183     71  
Total current liabilities $ 74,292     $ 88,967  
Long-term liabilities:      
Convertible senior notes, net $ 1,128,690     $  
Operating lease liabilities, net of current portion 21,799     11,793  
Finance lease obligations and other long-term liabilities 488     149  
Total long-term liabilities $ 1,150,977     $ 11,942  
 
Commitments and Contingencies      
Stockholders’ equity:      
Preferred stock, par value $0.0001 per share—500,000 shares authorized, none issued and outstanding $     $  
Common stock, par value $0.0001 per share—500,000,000 shares authorized; 63,326,309 and 62,820,351 shares issued and outstanding at October 2, 2021 and December 31, 2020, respectively 6     6  
Additional paid-in capital 503,690     560,210  
Accumulated deficit (296,601 )   (194,867 )
Accumulated other comprehensive income 10     1,748  
Total stockholders’ equity $ 207,105     $ 367,097  
Total liabilities and stockholders’ equity $ 1,432,374     $ 468,006  
       
 
BEYOND MEAT, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(In thousands)
(unaudited)
    Nine Months Ended
    October 2,2021   September 26,2020
Cash flows from operating activities:        
Net loss   $ (101,734 )   $ (27,675 )
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization   14,910     9,276  
Non-cash lease expense   2,351     1,573  
Share-based compensation expense   21,624     20,377  
Loss on sale of fixed assets   199     218  
Amortization of debt issuance costs   2,338     195  
Loss on extinguishment of debt   1,037     1,538  
Equity in losses of unconsolidated joint venture   1,176      
         
Net change in operating assets and liabilities:        
Accounts receivable   (13,495 )   10,365  
Inventories   (73,557 )   (50,263 )
Prepaid expenses and other assets   (13,249 )   (9,444 )
Accounts payable   965     2,442  
Accrued expenses and other current liabilities   18,176     245  
Prepaid lease costs, non-current   (49,456 )    
Operating lease liabilities   (2,332 )   (1,584 )
Net cash used in operating activities   $ (191,047 )   $ (42,737 )
         
Cash flows from investing activities:        
Purchases of property, plant and equipment   $ (104,301 )   $ (38,048 )
Purchases of property, plant and equipment held for sale       (2,288 )
Proceeds from note receivable on assets previously held for sale       599  
Payment of security deposits   (132 )   (9 )
Net cash used in investing activities   $ (104,433 )   $ (39,746 )
         
Cash flows from financing activities:        
Proceeds from issuance of convertible senior notes   $ 1,150,000     $  
Purchase of capped calls related to convertible senior notes   (83,950 )    
Proceeds from revolving credit facility       50,000  
Debt issuance costs   (23,605 )   (1,224 )
Debt extinguishment costs       (1,200 )
Repayment of revolving credit facility   (25,000 )    
Repayment of revolving credit line       (6,000 )
Repayment of term loan       (20,000 )
Repayment of equipment loan       (5,000 )
Principal payments under finance lease obligations   (130 )   (52 )
Proceeds from exercise of stock options   7,554     6,491  
Payments of minimum withholding taxes on net share settlement of equity awards   (2,749 )   (1,736 )
Net cash provided by financing activities   $ 1,022,120     $ 21,279  
Net increase (decrease) in cash and cash equivalents   $ 726,640     $ (61,204 )
Effect of exchange rate changes on cash   675     (169 )
Cash and cash equivalents at the beginning of the period   159,127     275,988  
Cash and cash equivalents at the end of the period   $ 886,442     $ 214,615  
 
Supplemental disclosures of cash flow information:        
Cash paid during the period for:        
Interest   $ 323     $ 2,114  
Taxes   $ 24     $ 15  
Non-cash investing and financing activities:        
Non-cash additions to property, plant and equipment   $ 2,653     $ 2,545  
Non-cash additions to financing leases   $ 580     $  
Operating lease right-of-use assets obtained in exchange for lease liabilities   $ 14,269     $ 3,151  
Reclassification of other current liability to additional paid-in capital in connection with the share-settled obligation   $ 2,535     $  
Note receivable from sale of assets held for sale   $     $ 4,558  
                 

Non-GAAP Financial Measures

Beyond Meat uses the non-GAAP financial measures set forth below in assessing its operating performance and in its financial communications. Management believes these non-GAAP financial measures provide useful additional information to investors about current trends in the Company's operations and are useful for period-over-period comparisons of operations. In addition, management uses these non-GAAP financial measures to assess operating performance and for business planning purposes. Management also believes these measures are widely used by investors, securities analysts, rating agencies and other parties in evaluating companies in our industry as a measure of our operational performance. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP financial measures may not be computed in the same manner as similarly titled measures used by other companies.

Adjusted gross profit and Adjusted gross margin

Adjusted gross profit is defined as net revenues less cost of goods sold adjusted to exclude, when applicable, costs attributable to COVID-19 activities which are not considered to be part of the Company’s normal business activities. Adjusted gross margin is defined as Adjusted gross profit divided by net revenues.

Adjusted gross profit and Adjusted gross margin are presented to provide additional perspective on underlying trends in the Company’s gross profit and gross margin, which we believe is useful supplemental information for investors to be able to gauge and compare the Company’s current business performance from one period to another.

Adjusted net loss and Adjusted net loss per diluted common share

Adjusted net loss is defined as net loss adjusted to exclude, when applicable, costs attributable to COVID-19, as well as other special items, which are those items deemed not to be reflective of the Company’s ongoing normal business activities.

Adjusted net loss per diluted common share is defined as Adjusted net loss divided by the number of diluted common shares outstanding.

We consider Adjusted net loss and Adjusted net loss per diluted common share to be useful indicators of operating performance because excluding special items allows for period-over-period comparisons of our ongoing operations. Adjusted net loss per diluted common share is a performance measure and should not be used as a measure of liquidity.

Adjusted EBITDA and Adjusted EBITDA as a % of net revenues

Adjusted EBITDA is defined as net loss adjusted to exclude, when applicable, income tax (benefit) expense, interest expense, depreciation and amortization expense, restructuring expenses, share-based compensation expense, expenses attributable to COVID-19, and Other, net, including interest income, loss on extinguishment of debt and foreign currency transaction gains and losses. Adjusted EBITDA as a % of net revenues is defined as Adjusted EBITDA divided by net revenues.

Limitations related to the use of non-GAAP financial measures

There are a number of limitations related to the use of Adjusted gross profit, Adjusted gross margin, Adjusted net loss, Adjusted net loss per diluted common share, Adjusted EBITDA and Adjusted EBITDA as a % of net revenues rather than their most directly comparable GAAP measures. Some of these limitations are:

  • Adjusted gross profit and Adjusted gross margin exclude costs associated with activities deemed to be non-recurring or not part of the Company’s normal business activities, which are subjective determinations made by management and may not actualize as expected;
  • Adjusted net loss and Adjusted net loss per diluted common share exclude costs associated with activities deemed to be non-recurring or not part of the Company’s normal business activities, which are subjective determinations made by management and may not actualize as expected;
  • Adjusted EBITDA excludes depreciation and amortization expense and, although these are non-cash expenses, the assets being depreciated may have to be replaced in the future increasing our cash requirements;
  • Adjusted EBITDA does not reflect interest expense, or the cash required to service our debt, which reduces cash available to us;
  • Adjusted EBITDA does not reflect income tax payments that reduce cash available to us;
  • Adjusted EBITDA does not reflect restructuring expenses that reduce cash available to us;
  • Adjusted EBITDA does not reflect expenses attributable to COVID-19 that reduce cash available to us;
  • Adjusted EBITDA does not reflect share-based compensation expense and therefore does not include all of our compensation costs;
  • Adjusted EBITDA does not reflect Other, net, including interest income, loss on extinguishment of debt and foreign currency transaction gains and losses, that may increase or decrease cash available to us; and
  • other companies, including companies in our industry, may calculate Adjusted EBITDA differently, which reduces its usefulness as a comparative measure.

The following tables present the reconciliation of Adjusted gross profit and Adjusted gross margin to their most comparable GAAP measures, gross profit and gross margin, respectively, as reported (unaudited):

    Three Months Ended   Nine Months Ended
(in thousands)   October 2, 2021   September 26, 2020   October 2, 2021   September 26, 2020
Gross profit, as reported   $ 22,976     $ 25,528     $ 103,036     $ 96,870  
Repacking costs attributable to COVID-19       657         6,572  
Inventory write-offs and reserves attributable to COVID-19       1,104         1,104  
Adjusted gross profit   $ 22,976     $ 27,289     $ 103,036     $ 104,546  
                 
    Three Months Ended   Nine Months Ended
    October 2, 2021   September 26, 2020   October 2, 2021   September 26, 2020
Gross margin, as reported   21.6 %   27.0 %   28.3 %   31.8 %
Repacking costs attributable to COVID-19, as a percentage of net revenues   %   0.7 %   %   2.2 %
Inventory write-offs and reserves attributable to COVID-19, as a percentage of net revenues   %   1.2 %   %   0.4 %
Adjusted gross margin   21.6 %   28.9 %   28.3 %   34.4 %
                 

The following tables present the reconciliation of Adjusted net loss and Adjusted net loss per diluted common share to their most comparable GAAP measures, net loss and net loss per share available to common stockholders—basic and diluted, respectively, as reported (unaudited):

  Three Months Ended   Nine Months Ended
(in thousands) October 2, 2021   September 26, 2020   October 2, 2021   September 26, 2020
Net loss, as reported $ (54,816 )   $ (19,285 )   $ (101,734 )   $ (27,675 )
Repacking costs attributable to COVID-19     657         6,572  
Inventory write-offs and reserves attributable to COVID-19     1,104         1,104  
Product donations attributable to COVID-19 relief efforts             2,742  
Loss on extinguishment of debt         1,037     1,538  
Adjusted net loss $ (54,816 )   $ (17,524 )   $ (100,697 )   $ (15,719 )
  Three Months Ended   Nine Months Ended
(in thousands, except share and per share amounts) October 2, 2021   September 26, 2020   October 2, 2021   September 26, 2020
Numerator:              
Net loss, as reported $ (54,816 )   $ (19,285 )   $ (101,734 )   $ (27,675 )
Aggregate non-GAAP adjustments as listed above     1,761     1,037     11,956  
Adjusted net loss used in computing Adjusted net loss per diluted common share $ (54,816 )   $ (17,524 )   $ (100,697 )   $ (15,719 )
               
Denominator:              
Weighted average shares used in computing Adjusted net loss per diluted common share 63,280,122     62,487,152     63,111,703     62,114,399  
Adjusted net loss per diluted common share $ (0.87 )   $ (0.28 )   $ (1.60 )   $ (0.25 )
  Three Months Ended   Nine Months Ended
  October 2, 2021   September 26, 2020   October 2, 2021   September 26, 2020
Net loss per share available to common stockholders—basic and diluted, as reported $ (0.87 )   $ (0.31 )   $ (1.61 )   $ (0.45 )
Repacking costs attributable to COVID-19     0.01         0.12  
Inventory write-offs and reserves attributable to COVID-19     0.02         0.02  
Product donations attributable to COVID-19 relief efforts             0.04  
Loss on extinguishment of debt         0.01     0.02  
Adjusted net loss per diluted common share $ (0.87 )   $ (0.28 )   $ (1.60 )   $ (0.25 )
                               

The following table presents the reconciliation of Adjusted EBITDA to its most comparable GAAP measure, net loss, as reported (unaudited):

    Three Months Ended   Nine Months Ended
(in thousands)   October 2, 2021   September 26, 2020   October 2, 2021   September 26, 2020
Net loss, as reported   $ (54,816 )   $ (19,285 )   $ (101,734 )   $ (27,675 )
Income tax (benefit) expense   (23 )   55     27     70  
Interest expense   1,005     689     2,656     1,963  
Depreciation and amortization expense   5,703     3,421     14,910     9,276  
Restructuring expenses(1)   5,750     2,146     12,068     6,028  
Share-based compensation expense   6,385     6,842     21,624     20,377  
Expenses attributable to COVID-19(2)       1,761         10,418  
Other, net(3)   (759 )   85     631     829  
Adjusted EBITDA   $ (36,755 )   $ (4,286 )   $ (49,818 )   $ 21,286  
Net loss as a % of net revenues   (51.5 )%   (20.4 )%   (27.9 )%   (9.1 )%
Adjusted EBITDA as a % of net revenues   (34.5 )%   (4.5 )%   (13.7 )%   7.0 %

____________

(1)   Primarily comprised of legal and other expenses associated with the dispute with a co-manufacturer with whom an exclusive supply agreement was terminated in May 2017.
(2)   Comprised of $1.8 million in costs attributable to COVID-19, consisting of $1.1 million in inventory write-offs and reserves associated with foodservice products determined to be unsalable and $0.7 million in repacking costs in the three months ended September 26, 2020, and $10.4 million in costs attributable to COVID-19 consisting of $1.1 million in inventory write-offs and reserves associated with foodservice products determined to be unsalable, $6.6 million in repacking costs and $2.7 million in product donation costs related to our COVID-19 relief efforts in the nine months ended September 26, 2020.
(3)   Includes $1.0 million in loss on extinguishment of debt associated with termination of the Company's credit facility in the nine months ended October 2, 2021 and $1.5 million in loss on extinguishment of debt associated with the Company's refinanced credit arrangements in the nine months ended September 26, 2020.

 

Beyond Meat (NASDAQ:BYND)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Beyond Meat Charts.
Beyond Meat (NASDAQ:BYND)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Beyond Meat Charts.